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2.4.5.2. Combining Molecular Fingerprints and Maximal Common Subgraph 
 
The previously described algorithm (2.4.4,2.4.4.1,2.4.4.2,2.4.4.3) based solely on 
molecular fingerprint and percentage atomic weight was too stringent to find all the 
possible molecular interactions. Hence, a dynamic weighted matrix based on the 
combination of molecular fingerprinting (refer to section 2.4.4.1) and the maximal 
common subgraph discovery algorithm (refer to section 2.4.5) was used to identify all 
the connected subgraphs (metabolites) in the reaction process. 
 
2.4.5.3. Mapping Function for the Dynamic Weighted Matrix 
 
Problem: Given a subgraph 'G  of reaction and compounds, find all the possible links 
between the substrate and product metabolites based on the molecular structure 
similarity. 
 
Solution: In order to identify most similar structures a constraint based search 
approach was conducted. Starting point for the analysis was a matrix M (refer to 
section 2.4.4.3), where each row uM  and column vM  in the matrix is filled with the 
similarity u,vS   (refer to section 2.4.4.3 and equation (2.15) ) for a specified subgraph 
'
G  (reaction, metabolites). The search for the most similar structures is conducted by 
maximizing the value of uM  in mutual dependency of vM  and vice versa or, in other 
words by minimizing the loss. 
 
Lemma 1: (Calculation of similarity between two molecules) Let '1,2H  be the MCS 
(refer to section 2.4.5) of given graphs 1G  (substrate) and 2G  (product). The selected 
pair (substrate and product) is then mapped using MCS algorithm and the matched 
sub-structure pattern is removed from the data set (using divide and conquer 
technique). Hence the resulting graph is '1,2 1( )H G   and 
'
1,2 2( )H G  .  
 
The matrix is refilled with the similarity score u,vS  between the remaining metabolite 
structures in the matrix and the process of selection is started iteratively again until 
no more mapping can be done or the similarity score equals zero (for a perfectly 
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balanced reaction)(Figure 15) (Figure 16). Here the length of the matrix is dependant 
on the stoichiometry∗ of the substrate and products.  
 
Figure 15. The remaining structures in the data set are mapped using the same concept of MAX-
MAX domination of the similarity score (S) in row/column of the matrix (M). The mapping 
shows A being mapped to D and B being mapped to C. The mapped structures are again 
removed from the dataset (This is done by mapping them using MCS algorithm. The common set 
of nodes and edges are deleted from the structure graph). As there is no further data to be 
mapped in the dataset, the algorithm automatically terminates the mapping search. 
                                                           
∗ "Die stöchyometrie (Stöchyometria) ist die Wissenschaft die quantitativen oder 
Massenverhältnisse zu messen, in welchen die chymischen Elemente gegen einander 
stehen." [Stoichiometry is the science of measuring the quantitative proportions or 
mass ratios in which chemical elements stand to one another.] … Jeremias Benjaim 
Richter, 1792 
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Figure 16. Based on the structural similarity score, structure A is mapped to structure C and 
structure B is mapped to structure E, as they dominate the scores in rows/columns in the 
Dynamic Weightage Matrix (M). The mapped part of the structure is then removed from the 
data set (This is done by mapping them using MCS algorithm. The common set of nodes and 
edges are deleted from the structure graph). 
 
Thus we were able to find better mapping between substrate and product as each and 
every pattern, including the sub-structural pattern was mapped (Figure 17). This 
allows us to understand the conserved functional structural patterns and identify 
conserved links between different cellular processes. 
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Figure 17. Metabolite mapping obtained from our old algorithm shows that ATP maps to ADP 
(thick black line) and D-Glucose maps to D-Glucose-6phosphate (thick black line), whereas the 
improved algorithm can also predict mapping between ATP and D-Glucose-6phosphate (thin 
black line). The new algorithm is able to match all the possible structure patterns between 
substrate and product. This algorithm can further be extended for classification of reactions and 
enzymes apart from path-finding. 
 
 
2.4.6. Adaptive Breadth First Search Algorithm (BFS) Under Constraints 
 
 
Problem:  Find the k-shortest path between source u and sink v, such that dG (u, v) of 
two vertices u,v V ! is the minimum number of edges of shortest paths between u and 
v in G. 
 
 
Input:  Given a graph pruned network 
'
G  of the original G = (V, E, L): 'G G! . 
Solution: Applying the breadth first search algorithm on the pruned network 
'
G , and 
find all the possible k-path of same length from a single source u to all the sinks v,  
via set of edges E 
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The modified BFS algorithm of Newman (Newman 2001) was further modified by 
constraining search space in the un-weighted graph G of the metabolic network. 
Providing the algorithm with some knowledge about the search space did this.  
 
Definition 18: Given a bipartite graph ( , , )G V E L= and its pruned graph 
' ' '( , , )G V E L= obtained from section 2.4.5.3 apply the BFS algorithm for finding 
shortest path uv!  in the network. If the given network is a directed bipartite graph 
| |G , then the search space will further reduce by direction constraints !" in 'E . 
 
 
Proof:  
Condition (a): Given a set of subgraphs Gi = (Vi, Ei, L) of a graph G. Where each 
source ( )iu V G! and ( )iv V G! sink is associated with reaction L(v) L! and each edge 
uv E (G) ! represents the reaction between u and v. 
 
Condition (b): Given a pruned subgraph ' ' 'i i iG  = (V , E , L)  of a graph G. Where each 
source ' '( ')u V G! and ' '( ')v V G! sink is associated with reaction ( ')L V L! and each 
edge ' ' '( )u v E G! represents the reaction between ' 'u  and  v . As | | ' |E   |E! , 
therefore | ' |G   |G|! . 
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2.4.7.        Tracking Changes in Metabolite Structural Patterns 
 
The metabolic network is a collection of metabolites that share certain common 
pattern between them to form links. Hence keeping track of the changes in these 
structure patterns in a defined path will help us understand the intricacies of the 
network. 
 
The tracing of the metabolite structure patterns can be divided into two parts. While 
traversing through the metabolic pathway it is possible to set the similarity measure 
score (Atom Mapper) between interacting molecules, and to define minimum amount 
of structure conserved with respect to this reference molecule at each reaction step 
(Atom Tracer). 
 
2.4.7.1.  Local Similarity (Atom Mapper) 
 
Local similarity is defined as the minimum amount of structure change conserved 
between two interacting metabolites (substrate and product) in the network with 
respect to the substrate metabolite. 
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Let u,v be the intermediate metabolites in a given graph G    (2.20) 
 
If we define  u! as the set of all elements iu!  in vector 
u
!  whose value is 1 (the 
"on" bits) and v!  as the set of all elements iv!  in vector 
v
!  whose value is 1. 
Hence applying equation (2.8) and (2.10), we can deduce the following equation 
(2.21). Hence the “Local Similarity” sL  between two intermediate metabolites in the 
network can be defined as  
100
u v
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L
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2.4.7.2.   Global Similarity (Atom Tracer) 
 
i i iLet u ',v ' be the intermediate metabolites in a given subgraph G ' of G            (2.22) 
i+1 i+1 i+1
Let u' ,v'  be the intermediate metabolites in a given subgraph G'  of  G (2.23) 
-1n-1 n-1  n
Let u' ,v'  be the intermediate metabolites in a given subgraph G' of  G
    (2.24) 
n n  n
Let u' ,v'  be the intermediate metabolites in a given subgraph G' of  G
         (2.25) 
'' ' '
i i+1 n-1 nwhere as u = u , ......,u v=           (2.26) 
 
Hence we can trace a common substructure k! along a give shortest path ' ',
i n
u v
! path 
by the following equation based on the equations (2.22), (2.23),(2.24), (2.25),(2.26) 
 
' ' ' ' ' '
1 2 1.........k i i i k n nu u u u u v! + + "= # # # # #   (2.27) 
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Thus the “Global Similarity” (2.28) along between two metabolites (source and sink) 
can be derived by equations (2.27),(2.26) 
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2.4.8.   Pathway Analysis under Constraints 
 
Predefined exclusion of small metabolites (like ATP, ADP etc) or vertices in the 
graph in the metabolic pathway may lead to broken links in the network or longer 
connectivity. This means that at each reaction step the algorithm should be able to 
decide, which metabolite to choose for further connectivity in the pathway and which 
to skip. Our new algorithm automatically discriminates between side metabolites (like 
ATP, ADP, Water, CO2 etc) and main metabolites while finding the shortest path.  In 
order to increase the flexibility of the path finding algorithm, few constraints are 
allowed on the system. 
 
There are sets of user-defined constraints, which can be used for an in-depth network 
analysis without affecting the biochemical/biological relevance.  
 
• While traversing through the metabolic pathway it is possible to set the 
similarity measure score (Atom Mapper refer to section 2.4.7.1) between 
interacting molecules and to define the amount of structure change with 
respect to his reference molecule at each reaction step (Atom Tracer refer to 
section 2.4.7.2).  
• By setting the Minimum path length (defined by shortest path) and 
Maximum path length (a heuristic measure defined by next shortest path by 
not including all the previous visited edges in shortest path) between two 
metabolites in the network, the reported path can be altered. For example, if 
the minimum path length is set to six, then the algorithm will drop paths 
below it and report the next possible shortest path above or equal to six, which 
is the shortest possible path under the given constraint. 
• A reaction cannot repeat itself in a given path or no cycle can be observed in 
the reported paths, both at level of metabolites and reactions. Also no 
substrate in a path can become connected product in the next step.  
• It is possible set certain on constraints on the path finding algorithm like via 
Metabolite (preference for certain vertices in the graph), not via Metabolites 
(exclusion/deletion of certain vertices in the graph) and not via Enzymes 
(exclusion/deletion of certain edges in the graph). 
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• It is possible to build a tailored network of metabolites and reactions from the 
existing network as reference in the database under the option of Build 
Virtual Organism. This is very useful for identification of the missing links 
in the network. 
 
2.4.9. Variants of the Algorithm 
 
The algorithm in Pathway Hunter Tool (PHT) supports four options.  
 
• Find k-shortest path to convert one metabolite into another in a given network 
(organism-specific or general metabolic network). 
• Find k-shortest paths from a substrate metabolite to all feasible metabolites in a 
given network (organism-specific or general). 
• Find k-shortest path to a product metabolite from all feasible substrate metabolites 
in a given network (organism-specific or general). 
• Statistical analysis of the metabolic pathways like average path length , diameter 
of the network, average node connectivity, loose ends in the network, hubs in a 
given network (organism-specific or general). 
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2.5. Results 
 
This section highlights the different properties of a metabolic path. All the 
analyses are carried out using Pathway Hunter Tool (PHT). 
 
2.5.1. Shortest Path Analysis Without Atom Mapper and Atom Trace 
 
           The shortest path analysis between Pyruvate and L-Lysine in an amino acid 
producing bacteria Corynebacterium glutamicum results (Figure 18) (Figure 19) in 2 
steps (undirected network) and 3 steps (directed network) respectively. Both the 
reported shortest paths are not valid in biochemical context as they are through a side 
metabolite or a promiscuous metabolite (highlighted in red). Hence we need an 
algorithm to skip such promiscuous metabolites while finding shortest path.  
 
Figure 18. Shortest path between Pyruvate and L-Lysine in Corynebacterium glutamicum (cgl)  
on an undirected metabolic network without mapping information 
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Figure 19. Shortest path between Pyruvate and L-Lysine in Corynebacterium glutamicum (cgl) on 
a directed metabolic network without mapping information 
One option is to delete all such promiscuous metabolites from the network by 
manually assigning the valid connectivity in the pathway as in the case of KEGG 
pathway chart. Using such manually curated pathway charts like KEGG may give 
valid and known biochemical information. Here the shortest path results in 11 reaction 
steps (Figure 20).   
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Figure 20. Shortest path between Pyruvate and L-Lysine in Corynebacterium glutamicum (cgl)  on 
a directed metabolic network with KEGG mapping information 
 
2.5.2. Mapping Examples between Metabolites in a Pathway 
 
One of the shortest paths between beta-D-glucose and 6-Phospho-D-gluconate 
highlights the structural similarities between the connecting metabolites. The mapping 
of metabolites in the pathway and their structural similarity based upon binary 
fingerprint is highlighted in (Figure 21).  
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Figure 21. Tracing and mapping metabolites in reaction pairs found in a biochemical conversion 
pathway.  
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2.5.3. Shortest Path Analysis with Atom Mapper and Atom Tracer 
 
The shortest path between pyruvate and L-lysine in Corynebacterium glutamicum 
comprises of 7 reaction steps as per our mapping algorithm (Figure 22) . The “Atom 
Mapper” was set to 15% (refer to 2.4.7.1) and “Atom Tracer” (refer to 2.4.7.2) was set 
to 5%. The obtained path is shorter than the normal shortest path obtained by KEGG 
pathway map by 4 reaction steps (refer to section 2.5.1). This is indeed a strong 
indicator that biochemical mapping would enable the analysis of genome-environment 
interactions, such as the prediction of new pathways (Figure 23). Such a study can 
highlight reactions, enzymes and genes that would degrade new environmental 
compounds. 
 
Figure 22. Shortest path between pyruvate and l-lysine in Corynebacterium glutamicum comprises 
of 7 steps as predicted by new mapping algorithm. This path is much shorter than the usual path 
obtained from hand-drawn maps available through KEGG. 
Chapter 2                                                                           Shortest Path Analysis in Metabolic Networks 
66 
 
Figure 23. Shortest path between pyruvate and l-lysine in Corynebacterium glutamicum comprises 
of 7 steps as predicted by new mapping algorithm. This picture highlights the genes, metabolites 
and enzymes required for conversion (as obtained using Pathway Hunter Tool). 
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2.5.3.1. Local and Global Similarity Score and its Impact on Path Finding 
 
The local and global similarity score define the minimum amount of structural 
similarity expected in the reported path. In order to demonstrate the impact of these 
scoring functions Escherichia coli K12 MG1655 was chosen as our model organism. 
The shortest path between “beta-D-glucose” and “pyruvate” was calculated. If the 
local similarity is increased step by step till no more paths are found, the path length 
increases with similarity score (Table 3). The impact of global similarity on the path 
length is very drastic as seen in the following example (Table 4). Hence, number of 
links in the network is inversely proportion to the local and global similarity score. 
Table 3. Local similarity and its impact on the shortest path. Higher the similarity score, longer 
the path as many links are skipped. 
Atom Mapper Atom Trace Path Length Number of Paths
10 5 5 1
15 5 5 1
20 5 6 2
25 5 7 1
30 5 7 1
35 5 7 1
40 5 10 1
45 5 0 0
50 5 0 0
60 5 0 0  
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Table 4. Impact of the Global similarity on the length of the reported shortest path. 
Atom Mapper Atom Trace Path Length Number of Paths
10 1 5 1
10 5 5 1
10 10 5 0
10 15 0 0
15 1 5 1
15 5 5 1
15 10 5 1
15 15 0 0
15 20 0 0
20 1 6 2
20 5 6 2
20 10 7 1
20 15 0 0  
 
2.5.4. Shortest Path Analysis of the Escherichia coli  
 
The shortest path in various Escherichia coli strains was calculated using metabolites 
mapping information (the algorithm explained in sections 2.4.5 and 2.4.7). The 
shortest path between beta-D-glucose and pyruvate using “Atom Mapper” (refer to 
2.4.7.1) as 15% and “Atom Tracer” (refer to 2.4.7.2) at 5% resulted in 5 reaction steps 
in Escherichia coli CFT073 (Figure 24) , Escherichia coli O157:H7 EDL933 (Figure 
25) , Escherichia coli K-12 W3110 (Figure 26), Escherichia coli K-12 MG1655 
(Figure 27), Escherichia coli O157:H7 Sakai (Figure 28). 
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Figure 24. Shortest path between beta-D-glucose and Pyruvate in Escherichia coli CFT073 
comprises of 5 steps with local similarity 15% and global similarity 10%. 
Chapter 2                                                                           Shortest Path Analysis in Metabolic Networks 
70 
 
Figure 25. Shortest path between beta-D-glucose and Pyruvate in Escherichia coli H7 EDL933 
comprises of 5 steps with local similarity 15% and global similarity 10%. 
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Figure 26. Shortest path between beta-D-glucose and Pyruvate in Escherichia coli K12 W3110 
comprises of 5 steps with local similarity 15% and global similarity 10%. 
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Figure 27. Shortest path between beta-D-glucose and Pyruvate in Escherichia coli K12 MG1655 
comprises of 5 steps with local similarity 15% and global similarity 10%. 
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Figure 28. Shortest path between beta-D-glucose and Pyruvate in Escherichia coli H7 Sakai 
comprises of 5 steps with local similarity 15% and global similarity 10%. 
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2.5.4.1.   Network properties 
 
The comparative study (Table 5) of a pathogenic Escherichia coli O157:H7 strain and 
a non-pathogenic bacteria Corynebacterium glutamicum is presented in (Table 6) and 
(Table 7).  The results are solely based on the network connectivity. 
Table 5. Escherichia coli O157:H7, Corynebacterium glutamicum and their network features like 
Degree Distribution (DD) = 2*N/L, Average Path Length (APL), Average k-Path Length (AKPL)    
Organism Genes Enzymes Reactions Metabolites DD APL AKPL
Escherichia coli O157:H7 Sakai 5341 586 1050 1044 3.52 8.06 8.52
Corynebacterium glutamicum ATCC 13032 3057 435 899 1069 2.8 8.22 8.88
 
Table 6. Top 10 metabolite hubs in Escherichia coli O157:H7 Sakai based on connectivity and 
ranked by incoming degree. 
Metabolite  Incoming degree  Outgoing degree
Pyruvate 26 24
CoA 18 14
Tetrahydrofolate 13 8
ATP 12 19
5-Phospho-alpha-D-ribose 1-diphosphate 11 10
L-Glutamate 11 15
Succinate 11 6
Acetate 10 7
beta-D-Fructose 6-phosphate 10 9
D-Galactose 10 5  
Table 7. Top 10  metabolite hubs based on metabolite connectivity in Corynebacterium 
glutamicum (Ranked by incoming degree). 
Metabolite  Incoming degree  Outgoing degree
Pyruvate 14 15
CoA 14 14
Tetrahydrofolate 13 8
Acetate 10 6
L-Glutamate 10 13
5-Phospho-alpha-D-ribose 1-diphosphate 9 10
Succinate 9 6
Acetyl-CoA 8 5
L-Homocysteine 8 4
D-Ribose 5-phosphate 7 6
Glycine 7 6
UMP 7 7
ATP 7 11  
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2.5.4.2. Top 10 Hubs based on k- Shortest Paths 
 
The top 10 metabolite hubs based on the shortest path analysis in a pathogenic 
Escherichia coli O157:H7 strain (Table 8) and a non-pathogenic bacteria 
Corynebacterium glutamicum) (Error! Reference source not found.) are presented.  
Table 8. Shortest path (SP) based top 10 incoming metabolite hubs in Escherichia coli O157:H7. 
Metabolite SP (IN) SP (IN) Normalized SP (OUT) SP (OUT) Normalized 
Pyruvate 74061 6.08 74273 6.08
5-Phospho-alpha-D-ribose 1-diphosphate 72466 6.06 72185 6.05
(2R)-2-Hydroxy-3-(phosphonooxy)-propanal 49825 5.68 50040 5.68
D-Ribose 5-phosphate 43499 5.54 43509 5.54
beta-D-Fructose 6-phosphate 43283 5.54 43377 5.54
D-Xylulose 5-phosphate 40630 5.48 40781 5.48
AMP 38323 5.42 38049 5.41
UMP 37962 5.41 37709 5.4
Glycerone phosphate 36096 5.36 36229 5.36
D-Ribulose 5-phosphate 35610 5.34 35665 5.35
 
 
The paths were normalized by using the following formula, ( )log msp
sp
!
!
" #
$ %$ %
& '(
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2.5.4.3. Shortest Path Distribution 
 
The Shortest path distribution in a pathogenic Escherichia coli O157:H7 strain and a 
non-pathogenic bacteria Corynebacterium glutamicum are presented in (Table 9). 
This global similarity was chosen as 5% and Local similarity was chosen as 15%. The 
percentage of shortest path in each organism is presented in (Table 10). 
Table 9. The shortest path distribution between Escherichia coli O157:H7 strain and a non-
pathogenic bacteria Corynebacterium glutamicum, calculated by Pathway Hunter Tool using 
CUBIC mapping algorithm (Local similarity 15%, Global similarity 5%). 
Shortest Path Distribution
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Table 10. Distribution of the shortest path percentage in the pathogenic Escherichia coli O157:H7 
strain and a non-pathogenic bacteria Corynebacterium glutamicum 
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3 Biochemical Pathway Alignment 
3.1  Introduction 
Equation Chapter 3 Section 3  
A metabolic network can be referred to as a set of interconnected enzymes and small 
molecules giving rise to anabolic, catabolic and amphibolic pathways. The underlying 
cellular topology may vary from organism to organism and this may give rise to 
different functionalities of a pathway(Ravasz, Somera et al. 2002). It is interesting to 
understand how the connectivity between the networks affects the conversion of 
metabolites (Hartwell, Hopfield et al. 1999; Csete and Doyle 2002). Some 
connectivity in the network may be conserved across many genomes (Kelley, Sharan 
et al. 2003) and vice versa. Thus it is essential to understand the underlying functions 
of these cellular networks and the cross-talk between them (Chen and Vitkup 2006; 
Rahman 2006). 
 
Metabolic enzymes represent one of the most important classes of proteins and 
extensive studies about their sequence, structure and function have been carried out in 
the past (Rison, Teichmann et al. 2002). Many enzyme families usually catalyze a 
range of biochemical reactions (Jensen and Gu 1996; Dandekar, Schuster et al. 1999), 
whereas some of these reactions may also be catalyzed by members of apparently 
unrelated protein families (Copley and Bork 2000). This fortifies the hypothesis that 
metabolic enzyme families exhibit complex patterns of divergent and convergent 
evolution (Hartwell, Hopfield et al. 1999; Albert, Jeong et al. 2000; Chen and Vitkup 
2006). The functional assignment by homology (Iliopoulos, Tsoka et al. 2001; Chen 
and Vitkup 2006) to proteins of known function may overlook issues of evolutionary 
divergence (Castresana 2001; Chen and Vitkup 2006), which may lead to error 
propagation in sequence databases (Karp 1998). Understanding the enzyme sequence 
and function(s), based on the metabolic pathway provides us with a better and deeper 
understanding of the system (Rison, Teichmann et al. 2002) (Teichmann, Rison et al. 
2001; Tsoka and Ouzounis 2001) . 
 
In recent years there have been major efforts to understand metabolic pathways based 
on the concept of pathway alignment (Dandekar, Schuster et al. 1999; Tohsato, 
Matsuda et al. 2000; Matsuda and Tohsato 2001; Kelley, Sharan et al. 2003; Brandes, 
Dwyer et al. 2004; Chen and Hofestadt 2004). In one such study the power of a 
Chapter 3                                                                                                 Biochemical Pathway Alignment 
 
80 
comparative study of pathways captured the plasticity of the glycolytic pathway 
(Dandekar, Schuster et al. 1999). These researches highlight the need for robust 
algorithms to perform pathway reconstruction and pathway alignment for facilitating 
the discovery of pharmacological targets and complementing biotechnological 
applications.  
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3.2  Background 
 
With the stock pile of already sequenced genomes ever increasing, computational 
reconstruction of metabolic networks becomes a crucial step for metabolic pathway 
analysis. Robust methods and tools are required to detect and bring out conserved and 
diverged metabolic pathway connectivity (enzymes/metabolites) in various genomes. 
One such method is metabolic pathway alignment, which can help us understand the 
cross-talk between pathways arising from the underlying connectivity at the 
biochemical level. Alignment tools would find application in various areas, such as 
genome annotation and would prove valuable to a wide range of users including 
pharmacologists, metabolic engineers etc. 
 
3.3  Proposed Model 
 
We present a novel method to perform pathway alignment based on the shortest path 
as implemented in Pathway Hunter Tool (PHT) (Rahman, Advani et al. 2005). The 
output of the pathway aligment will highlight the convergence/divergence of small 
molecule(s) coding enzyme-enzyme connectivity in the pathway across genomes. In 
the first section of this chapter enzymes usage matrix obtained from the ab-initio 
reconstructed network based on the shortest path analysis is presented In the second 
section the alignment procedure together with insertions for handling missing links in 
the network(s) is introduced. The visualization aspect of the alignment, which presents 
the connectivity information from the obtained matrix, highlighting the intricacies of 
the pathways in the selected organism is discussed. Thus we combine the top down 
and bottom up approach to perform the metabolic pathway alignment on the 
reconstructed metabolic network of the selected genomes from KEGG (Kanehisa, 
Goto et al. 2004) are combined. The standard Gibbs energy (Mavrovouniotis 1991) 
change of reactions has been used as an indicator to score/ rank the biochemical 
flexibility of the pathways. The Gibbs energy-based thermodynamics curve (with an 
option to add metabolite concentration data for the calculation) of selected 
((Mavrovouniotis 1993) and references therein), aligned pathways can then be viewed 
and compared. 
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3.4  Method 
 
Exploring the pathway capabilities in different organisms based on connectivity 
information helps us understand the evolutionary relationship (Forst and Schulten 
1999; Forst and Schulten 2001; Teichmann, Rison et al. 2001) as well as alternate 
pathways (Dandekar, Schuster et al. 1999; Heymans and Singh 2003) available in 
various species ( i.e. Prokaryote, Eukaryote). Using graph theory one can define the 
metabolic network as a directed graph where 
G = (V, E) V  metabolites and E  enzymes! ! .  
 
The general procedure used in PAT to perform pathway alignment can be described 
as: 
 
3.4.3 Data Collection 
 
Collecting the connectivity information from the metabolic network of the 
genomes by, a) Selecting organisms from the evolutionary tree based on KEGG 
(Kanehisa, Goto et al. 2004) ontology; and b) Building a consensus network and 
percentage enzyme occurrence matrix (refer to 3.4.6) from the selected organisms 
(Figure 29).  
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Mtcmtuecocgl
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5.4.2.15.3.1.94.1.2.133.6.1.72.7.2.32.2.1.11.2.1.12Enzymes
 
Figure 29. Enzyme-Percentage occurrence matrix resulting from the conversion of beta-d-glucose 
to pyruvate in the reconstructed network of cgl, eco, mtu, mtc. 
 
3.4.4 Path Finding 
 
Querying a pathway between two metabolites with or without insertion(s) of 
enzymes in the queried pathway by, a) Finding the shortest path between source and 
destination metabolites in selected organisms; and b) If possible, finding and 
extending the shorter shortest path in a genome(s) to match the longer shortest path of 
other genome(s).  
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3.4.5 Viewing Aligned Path 
 
The user views the alignment output and saves it as an image (PNG, JPEG, 
GIF format). Enzymes are coloured (Figure 30) according to their percentage 
occurrence in the selected reference matrix. A consensus of the alignment is 
represented by bar charts and they are coloured according to the enzyme preference 
along the aligned pathway. 
 
Figure 30. Color code for representing the percentage occurrence of enzymes in the organisms. 
Insertion(s)/Deletion(s) of enzymes in the alignment is represented by white colors. 
 
3.4.6 Enzyme-Percentage Occurrence Matrix and Enzyme-Enzyme 
Connectivity Matrix 
 
The enzyme-percent matrices (refer to 3.4.3) were constructed for three 
classes of organisms - Bacteria, Eukaryote, Archae; representing the percentage 
occurrence (3.1) of each enzyme Mi,j (E) occurring in selected organism(s)(“i” th 
enzyme is “j” th organism).   
 
m
j j
j=1
Let = O  {  j   Organisms}! " #$  (3.1) 
 }{
n
i,j (E) i,j j
j=1
M   =  E /    100  i  Enzymes |1<i<m!
" #
$ % & ' (
$ %
) *
+  (3.2) 
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The resulting matrix named as Enzyme-percentage matrix (3.2) highlights the 
percentage occurrence of an enzyme across the selected genome. For example the 
enzyme-percentage occurrence matrix for the conversion of beta-D-glucose to 
pyruvate will appear as shown in (Figure 29). The enzyme 3.6.1.7 is absent in 
Mycobacterium tuberculosis H37Rv (mtu) hence its percentage occurrence is 75%. 
 
Enzyme-enzyme connectivity matrix is a sparse matrix, which contains information 
about the neighbours of each enzyme. An enzyme is connected to another enzyme if 
and only if it shares a common metabolite between them in a pathway. Finding the 
shortest path in the network under a certain criterion of local and global similarity 
score between all the metabolites in the network is used to calculate this matrix. 
 
3.4.7 Pathway Alignment Based on Shortest Path using the Matrices 
 
The basic alignment procedure revolves around the shortest path between a source 
and destination metabolite. The general alignment procedure can be defined by the 
following flow chart (Figure 31). 
 
3.4.8 Organizing Consensus Header and Assigning Color Codes 
 
Generating a consensus header from the alignment provides a global view of the 
alignment. The preference of the organism for certain enzymes at each step of the 
conversion can be viewed instantly (Figure 31). However, the length of these paths 
may vary from one organism to another. This may prove to be a hitch for the 
alignment. To overcome this problem a new method, “building reference headers” is 
implemented. In the “Building reference headers” method separates reference headers 
are built with different path lengths and the paths with identical path lengths are 
aligned to their corresponding reference header. At the local level, such results 
indicate whether or not an enzyme is unique to an organism. This is done by 
examining its percentage occurrence in various organisms which is presented in the 
enzyme percentage matrix where each enzyme is color coded (Figure 30) based on its 
percentage occurrence. 
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The resulting output increases the potential for biochemical/metabolic engineering 
application and has the potential to facilitate the ongoing systems biology research 
outlook for deciphering the genomes. 
Chapter 3                                                                                                 Biochemical Pathway Alignment 
 
87 
 
 
Figure 31. A flowchart for the proposed pathway alignment model. 
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3.4.9 Finding Alternate Paths based on Metabolites and Enzymes 
 
There can be more than one path for converting a substrate to the final product after a 
series of reaction steps. These paths were classified on the basis of the 
metabolites/enzymes (iso-enzymes) involved at each step of conversion. 
 
Two levels of coding - “x.y” were used to classify the pathways. If an alignment 
between two metabolites results in three paths and if the first two paths evolve with 
the same set of connecting metabolites (but with alternate enzymes doing this 
conversion). Then this path is shown as “1.1” and “1.2” is represented by “y”. 
However in the third path, one of the connecting metabolites used for conversion has 
changed but the source and end product metabolites of the path remains unaltered. 
This path is therefore represented as “2.1” which is represented by “x”.  
 
Hence, this implies that the change in convention at the first level represents a 
change in at least one of the connecting metabolites during the conversion. If the 
second level changes then there is at least one change in the connecting enzyme(s) 
involved during the conversion. Thus the information about the alternate pathway is 
coded in the alignment procedure. 
 
3.4.10 Handling gaps in the pathway alignment 
 
It is well-acknowledged that a path between two metabolites might not be discovered 
due to the missing intermediate conversion step(s) (Osterman and Overbeek 2003; 
Green and Karp 2004; Brouns, Walther et al. 2006). This may happen due to lack of 
information about the pathway (i.e. lack of functional data). It would thus be of 
interest to insert or delete an enzyme in the system and observe the change(s) in the 
pathway alignment (Ettema, Makarova et al. 2004; Chen and Vitkup 2006). In terms 
of graph theory, we are interested in finding the shortest path with one or more 
inserted nodes (missing enzymes). This may change the entire search space and hence 
the topology of the network may also be affected (especially if the inserted enzyme is 
highly connected). Hence, this may result in a combination of paths (due to alternate 
paths) of different lengths thereby increasing the runtime of the alignment. The gap 
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handling subroutine holds true if and only if no path exists between two metabolites in 
an organism (Figure 31).  In order to avoid combinatory explosion, a maximum of 
five gaps (hypothetical enzyme(s) to be inserted in the path) is allowed in the 
alignment.  
 
For the purpose of better visualisation, insertion(s) in our system are reported in 
“white” color and a “+” sign is inserted bellow the consensus header. If an enzyme is 
unique to an organism it is represented in the colour “black”. Handling 
insertion/deletions in the pathway may help us improve the annotation in the 
organism. It would also cater to the requirements of pharmacological and bio-
technological research (Schilling and Palsson 2000; Papin, Price et al. 2003). 
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3.4.11 Algorithm Complexity for Handling Alignment  
 
Metabolic pathway alignment for various species may result in paths of different 
lengths between two metabolites under certain criteria of local and global similarity 
(refer to section 2.4.7) (Rahman, Advani et al. 2005). Hence it is important to build a 
consensus header from the alignment by encapsulating path(s) of equal lengths. In 
order to capture the local preference(s) of the enzymes in the selected organism(s) at 
various steps of the pathway, a consensus header is generated from the pathway(s) of 
different path lengths. This increases the quality of information representation without 
making the alignment visualization too complex.  
 
At the metabolic-centric level, paths of similar lengths were encapsulated and ranked 
according to the summation of standard Gibbs energy of reaction(s) (refer to section 
3.4.12) involved in each pathway. Standard Gibbs energy is an indicator of the 
tentative biochemical energy (thermodynamics) requirement for a pathway (i.e. G!  
of pathway may vary), thereby highlighting the biochemical nature of various 
pathways (Mavrovouniotis 1993).  
 
This information when combined with genomic data allows us to view the system in 
an extremely comprehensive manner (a comparative study of pathways between 
various metabolic networks of the genome(s) will highlight the preference for certain 
class/type of enzymes at various steps) (Kummel, Panke et al. 2006; von Stockar, 
Maskow et al. 2006). 
 
Computationally, this means that the Shortest Path sp!  between two metabolites in 
an organism of interest may result in k steps sp i( (O):= k | k O ) ! " and in another in 
“k + t” steps( )sp m i+m(O )= k+t | k+t O! " . This implies that the path length 
k k t< +  ( ( ) 'sp spo! !" < ) in the alignment. Hence we will get two consensus 
headers for each path length k and k + t respectively, whereas the summation of 
consensus headers will result in length k + t.  
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An alignment between paths of path length of k and k + t in organisms of interest, will 
require the extension of path length k to the next feasible path of length ‘k+t’ in the 
network. Finding next possible shortest path in a metabolic network is a NP-complete 
problem due to combinatory explosion arising from the topological search (i.e. its 
difficult to know that a next possible shortest path exists in the netwrok). To find the 
next possible shortest path in the system, PHT employs heuristics and hence may miss 
some paths in the alignment while looking for the next possible path.  
 
To overcome this situation, we backtrack (based on consensus header) after each 
search to find a possible path (if a path was missed, or no shortest path was reported) 
from the selected enzyme-enzyme connectivity matrix1. Though this may increase the 
running time of alignment in such cases, it greatly enhances the quality of the reported 
alignment - a trade-off that will pay high dividends to the potential users. 
                                                           
1 A sparse matrix containing information about enzyme-enzyme connectivity in the reference network 
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3.4.12 Gibbs Energy Profile of the Aligned Pathways 
 
Once pathways are aligned, they can also be compared with respect to Gibbs energy 
changes (refer to section 2.2) of each reaction step. The standard Gibbs energy of 
formation for each metabolite is computed by a group contribution method 
(Mavrovouniotis 1991). The basic method was further extended and adapted to cover 
metabolites containing vinylog acids and has been implemented in Java. Molecular 
structures are needed for this procedure and were extracted from the KEGG Ligand 
database (Kanehisa, Goto et al. 2006). They have been converted to their standard 
state at pH 7 using the pKa plugin of the ChemAxon software package JChem♣. The 
Gibbs energy prediction method has been applied to the modified structures to give 
the standard Gibbs energy of formation. By weighted summation of these values for 
each reaction, the standard Gibbs energy of reaction is obtainedℜ. The actual Gibbs 
energy of reaction may be calculated when concentration values of participating 
metabolites are at hand (Mavrovouniotis 1993). 
 
                                                           
♣ JChem, version 3.1.6, ChemAxon, Budapest, Hungary. www.chemaxon.com/products.html   
ℜ  Please refer Kai Hartmann’s PhD Work at CUBIC, Cologne, Germany 
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3.5 RESULTS 
 
In order to prove the potential of our new algorithm and method to perform metabolic 
alignment an alignment with the following bacterial genomes was performed.  
 
3.5.3 Comparative Study of Metabolic Network Topology between a 
Pathogenic and a Non-Pathogenic Bacterium 
For conducting a comparative study between Bacillus subtilis 168 and Bacillus 
anthracis Sterne metabolic network, we calculated shortest path distribution (Figure 
32), the average path length (Table 11) and average alternate paths (Figure 33). It is 
important to keep track of alternate paths in the metabolic network because this 
indicates the ability of the organism to survive in adverse conditions. 
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Figure 32. Shortest path distribution in B. subtilis 168 and B. anthracis Sterne 
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Average Alternate Path Distribution
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Figure 33. Average alternate path distribution in B. subtilis 168 and B. anthracis Sterne. The 
alternate shortest path in the network can be calculated by dividing the total number of shortest 
paths at each path length (reaction step) by the unique number of shortest path respectively 
Table 11. Metabolic network analysis of B. subtilis 168 and B. anthracis Sterne using shortest 
path 
Genome  Enzymes Reactions Metabolites Average Path 
Length (sp/k-
sp)
Diameter 
of the 
Network
Average 
Degree
B. subtilis 168 468 974 1081 7.93/8.59 28 3.06
B. anthracis 
Sterne 455 997 1127 7.98/8.73 28 3.01
 
Thus, blocking a path may not be lethal as organisms can switch to an alternate path 
performing similar conversions. Alternate paths can be bio-energetically costlier or 
longer than the native pathway. Hence though organisms may slow down their 
metabolic activity, they can still survive.  
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3.5.4 Performing Pathway Alignment 
 
For demonstrating the pathway alignment algorithm four bacterial pathogens i.e. 
Escherichia coli O157:H7, Mycobacterium tuberculosis CDC1551, Bacillus anthracis 
Sterne, Pseudomonas aeruginosa and a non-pathogenic bacteria Bacilus subtilis was 
chosen. The local similarity was set to 15% and global similarity was set to 5%. All 
these alignments were performed using Enzyme-Enzyme Connectivity Matrix and 
Enzyme-Percentage Occurrence Matrix built using over 150 bacteria in the PHT 
database inherited from KEGG. 
 
3.5.4.1 Pathway Plasticity between Bacteria 
  
In order to observe flexibility in the pathways of selected genomes, a comparative 
analysis based on the pathway alignment was performed. The shortest path was 
chosen that converts beta-d-glucose 6-phospate and citrate in selected genomes 
without gap (Figure 34).  
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Figure 34.  The pathway alignment between beta-D-Glucose 6-P and Citrate in four bacterial 
pathogens and one non-pathogenic bacterium.  The assigned local similarity is 15% and global 
similarity is 5% 
 
Figure 35. Progressive pathway alignment highlighting the enzymes preferred at various steps of 
the alignment 
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 Previous research has demonstrated that pathway plasticity even in the central 
pathway i.e. glycolysis and pentose pathway in not only often present but seems to be 
selected by evolution (Forst and Schulten 1999; Schmidt, Sunyaev et al. 2003). This 
section explains the results obtained from the alignment (Figure 35) and discusses its 
capabilities in the light of systems biology. 
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3.5.4.2 Pathway Alignment in Selected Organisms for Converting “beta-D-
glucose 6-phosphate” into “Citrate”     
 
The shortest path to convert “beta-D-glucose 6 phosphate” into “citrate” consists of 
six reaction steps in Escherichia coli O157:H7 and Pseudomonas aeruginosa and nine 
reaction steps in Mycobacterium tuberculosis CDC1551, Bacillus anthracis Sterne, 
and Bacilus subtilis (Figure 36).  
 
Figure 36. Progressive pathway alignment highlighting the enzymes preferred at various steps of 
the alignment. Consensus of the alignment is shown as bar charts and the percentage occurrence 
of each enzyme in bacteria is shown by the respective colors. 
 The alternate pathways (in terms of metabolites (Figure 37) and enzymes) are 
highlighted while performing the pathway alignment. The assigned colors in the 
enzyme block represent its percentage occurrence in bacteria (refer to section 3.4.5 
and 3.4.6). For example in the alignment result (Figure 34) enzyme “1.1.1.49” (at step 
1) occurs less than 70% times in bacteria (colour as green) whereas enzyme “2.7.2.3” 
(at step 5) occurs more than 90 % of the times in bacterial (colour red). Hence this 
global information is very well represented in the alignment-using colour coding 
schema. The local information about the aligned path is very well represented in the 
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terms of bar chats found above the consensus header of the alignment.  For example 
enzymes 3.1.1.31 (step 2) and 4.1.2.14 (step 4) are found to occur less than 30% time 
in this alignment. 
 
At each step of the alignment the headers display different preferences (looking at the 
percentage distribution) of the enzymes at various steps. This implies the existence of 
other enzymes in the path, which can perform similar tasks. The presence of an iso-
enzyme is shown in step 2 and step 3 of (Bacillus antracis) of the alignment where 
enzyme “2.2.1.1” (section 1.1) is substituted by enzymes “2.7.1.11” and “4.1.2.13” 
(section 1.2). Hence they perform the same conversion but in the presence of different 
cofactors thereby highlighting the need to example the metabolites involved in the 
conversion step. Hence the metabolic centric view (Figure 37) and the Gibbs energy 
profile can highlight further dynamics of the path and the moieties involved during the 
conversion process. Using the metabolic profile of the pathway alignment (example 
between step 3 and step 4) it is clear that there are different metabolites involved in 
intermediate conversion steps. Such findings will further boost the relevance of 
comparative network analysis across the genomes and highlights the crosstalk 
between the pathways.  
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Figure 37. Metabolic centric view of the alignment for the selected paths with deltaG score. 
Change is deltaG represents change in on of chemical compound constituting the reaction. 
 
 
This further highlight the fact that selected genomes has a preference for certain 
enzymes over others (based on functionality or evolutionary past) in select pathways 
to carry out certain conversions. Hence this method further provides a global and local 
view to the occurrence of an enzyme in species of interest and its possible relevance 
in the pathway. 
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3.5.5 Gibbs Energy Profile of the alignment 
 
The true meaning of the biochemical pathway can be measured quantitatively using 
Gibbs free energy (refer to 2.2). We have used Gibbs free energy to measure the 
biochemical cost (energy) of various pathways. Thus combining Gibbs free energy 
with biochemical pathway alignment is a very natural phenomenal. 
 
3.5.6 Pathway Alignment with Gaps (insertion)  
 
The shortest path in Helicobacter pylori for converting “3-phospo-D-Glycerate” to 
“pyruvate” has 3 reaction steps if an insertion is allowed while performing alignment. 
The result with an insertion in the alignment of E. coli k-12 (Figure 38) shows that a 
shorter path of length 3 alread exists in E.coli genome. The inserted enzyme is 
“2.7.1.40” shown in white color. In the header section the insertion is shown with a 
“+” sign. 
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Figure 38. The aligned paths between metabolites 3-phospho-D-glycerate and pyruvate in H. 
pylori and E. coli K-12.  The gaps in the alignment as represented by "+" in the header section.   
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The metabolic centric view (Figure 39) of the aligned path further highlights the 
conserved nature of the connecting metabolites between E.coli and H.pylori. 
 
Figure 39. The pathway alignment between 3-phospho-D-glycerate and pyruvate in H. pylori and 
E. coli K-12. The metabolic centric view of the pathway is shown here. 
The biochemical significance of the insertion can be studied by looking at the Gibbs 
profile of the aligned pathway. We performed the standard Gibbs energy profile of the 
aligned path (Figure 40) and found that bio-chemically this insertion is feasible (best 
results can be calculated by finding the gene coding of this enzyme and metabolic 
concentration data). 
 
Figure 40. The Gibbs energy profile the alignment pathway between 3-phospho-D-glycerate and 
pyruvate in H. pylori and E. coli K-12.   
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4 Load Point and Choke Point 
 
4.1 Introduction 
 
Equation Chapter 4 Section 4 
In the present “omics” era, it becomes increasingly more obvious that network 
analysis is essential for the analysis of genetic, proteomics and metabolomics data 
(Hartwell, Hopfield et al. 1999; Grigorov 2005). Large-scale, graph-based 
mathematical models have been developed to demonstrate the intrinsic hierarchical 
modularity of metabolic networks (Ravasz, Somera et al. 2002) and their robustness 
based on the shortest path analysis of the metabolic networks (Arita 2004; Barabasi 
and Oltvai 2004; Papin, Reed et al. 2004).  
 
A typical metabolic network consists of reactions, metabolites and enzymes, which 
can be modelled using graph theory (Jeong, Tombor et al. 2000; Schuster, Fell et al. 
2000; Girvan and Newman 2002; Oltvai and Barabasi 2002; Steinbeck, Han et al. 
2003). These representations lead from a simple graph consisting of edges (reactions) 
and nodes (metabolites) or vice versa to a complex bipartite graph where two nodes 
(metabolites) share a common node (reaction/enzymes) (Rahman, Advani et al. 2005). 
Joining enzymes that share a common metabolite in a path can create enzyme-centric 
networks. The enzyme-centric view (Horne, Hodgman et al. 2004; Rahman, Advani et 
al. 2005) simplifies the representation of the metabolic network by removing loose 
ends in the network (metabolites at the periphery of the network) and forming clusters 
of interacting enzymes. The gene-centric view has been successfully used in 
determining co-regulated genes in the metabolic and regulatory networks (Levchenko 
2003; Covert, Knight et al. 2004; Luscombe, Babu et al. 2004; Ozbudak, Thattai et al. 
2004; Barrett, Herring et al. 2005). 
 
In the present work we extend our analysis to the identification of “load points”. The 
“load points” analysis of metabolites in a metabolic network depends on the ratio of 
the number of valid k-shortest path passing through the metabolites and its nearest 
neighbour connectivity. We believe “load points” can complement other existing 
methods of metabolic network analysis (Schilling, Schuster et al. 1999; Steinbeck, 
Han et al. 2003; Klamt and Gilles 2004; Croes, Couche et al. 2005). It provides a 
global view to the metabolic network activity and such information might help in the 
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analysis of metabolic concentration data obtained from high throughput methods like 
GC/MS (Fiehn, Kopka et al. 2000; Strelkov, von Elstermann et al. 2004). A global 
perspective reveals that certain pathways such as the citrate cycle are highly used in 
the cell. Most of the enzymes/metabolites in the citrate cycle of glycolysis have high 
“load” values. The load point(s) analysis might help interpret concentration data, or 
flux data obtained by flux balance analysis or metabolic control analysis. Hence the 
importance of a metabolite in a metabolic network can be represented and ranked  
 
In chapter 2, an algorithm was developed to identify bio-chemically correct 
connectivity in the metabolic network (refer to section 2.4.4) by pruning the network 
based on metabolic structural similarity (Rahman, Advani et al. 2005). The concept of 
“Global” and “Local” similarity was used to find a valid connectivity in the network 
(refer to section 2.4.7). The effect of metabolic structural similarity on the reported 
path and connectivity is very significant as this determines the abstraction level of the 
sub-network (Hattori, Okuno et al. 2003).  
 
4.2  Formulation of the Critique  
 
In the present work we extend our analysis to the identification of “load points”. The 
“load points” analysis of metabolites in a metabolic network depends on the ratio of 
the number of valid k-shortest path passing through the metabolites and its nearest 
neighbour connectivity. We believe “load points” can complement other existing 
methods of metabolic network analysis (Schilling, Schuster et al. 1999; Steinbeck, 
Han et al. 2003; Klamt and Gilles 2004; Croes, Couche et al. 2005). It provides a 
global view to the metabolic network activity and such information might help in the 
analysis of metabolic concentration data obtained from high throughput methods like 
GC/MS (Fiehn, Kopka et al. 2000; Strelkov, von Elstermann et al. 2004). A global 
perspective reveals that certain pathways such as the citrate cycle are highly used in 
the cell. Most of the enzymes/metabolites in the citrate cycle of glycolysis have high 
“load” values. The load point(s) analysis might help interpret concentration data, or 
flux data obtained by flux balance analysis or metabolic control analysis. Hence the 
importance of a metabolite in a metabolic network can be represented and ranked by 
this method. 
 
Chapter 4                                                                                                        Load Point and Choke Point 
 
107 
Choke points are critical points in metabolic networks. Inactivation of choke points 
may lead to an organism’s failure to produce or consume particular metabolites which 
could cause serious problems for fitness or survival of the organism (Yeh, Hanekamp 
et al. 2004). We propose a new method to analyse choke points by screening the entire 
metabolic network of pathogens and report the probable choke points in the network. 
This extended graph theory model ranks the choke points according to the k-shortest 
path passing through it and the load (in/out) on it. This ranking has a major advantage 
as this measure may help determine the biochemical essentiality of a 
metabolite/enzyme (when a chokepoint enzyme is removed from the network). For 
example, in P. falciparum - a parasite causing malaria in humans, a host cell enzyme 
4.2.1.24 (d-aminolevulinate dehydratase; ALAD) involved in heme biosynthesis was 
suggested as an antimalarial target (Bonday, Dhanasekaran et al. 2000). This enzyme 
is also a choke point enzyme and identifying such potential targets in the pathogens 
can accelerate the drug discovery. Also all three clinically validated drug targets for 
malaria are chokepoint enzymes. A total of 87.5% of proposed drug targets with 
biological evidence in the literature are chokepoint reactions (Yeh, Hanekamp et al. 
2004).   
 
For building the biochemical network we used the LIGAND (Goto, Okuno et al. 
2002) database from KEGG (Kanehisa, Goto et al. 2004) as this data model is the 
backbone for the Pathway Hunter Tool (Rahman, Advani et al. 2005) in addition to 
BRENDA (Schomburg, Chang et al. 2004). For the predicted choke points in the 
pathogen we performed a homology search against the human genome using BLAST 
(Altschul, Madden et al. 1997). 
 
Here we provide a generic framework and model for an automated analysis of 
metabolic networks by ranking the metabolites on the basis of their load point 
property. Load points help determine the importance of enzymes and metabolites in 
the biochemical network. The concept of choke points was used in our study to find 
potential drug targets in the metabolic network of Bacillus anthracis Sterne. The 
metabolites and enzymes are further ranked on the basis of their loads in the given 
network. A comparative study was performed between the human metabolic network 
and pathogen choke points to discriminate human choke points from the pathogenic 
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bacterial choke points. A homology search was performed against human genome to 
find non-homologues potential drug targets from the pathogen choke points.  
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4.3  Method 
  
4.3.1 Data and System 
 
In order to demonstrate the efficiency of our algorithm we chose two microbial 
organisms, namely Bacillus subtilis 168 (Kunst, Ogasawara et al. 1997) and Bacillus 
anthracis Sterne (Read, Salzberg et al. 2002) from the KEGG database. B. subtilis is 
totally innocuous to man and has been widely used in scientific and industrial 
applications in the past. B. anthracis is a pathogen that causes anthrax, which in its 
pulmonary or digestive form is often lethal to humans. A comparative study of the 
metabolic networks of these two organisms highlights the analogies and differences 
between their respective pathways. Of course, there is sometimes more than one 
reaction for an enzyme in KEGG ligand database. Some of the potential reactions may 
be irrelevant to the organism, as the organism may not use all the reactions coded by 
an enzyme. 
 
4.3.2 Data Representation in Graph Theory 
 
Using graph theory we can define the system in terms of a bipartite graph (refer to 
section 2.4.2), which can be reduced to an enzyme-centric graph and a metabolic-
centric graph (refer to section 2.4.1.4). In a bipartite view, two nodes share a common 
enzyme and the edges define the biological relationship between a set of metabolites 
and enzymes. In the metabolic-centric view metabolites are nodes and 
reactions/enzymes are edges whereas in the enzyme-centric view, enzymes are nodes 
and metabolites are edges. 
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4.4   ALGORITHM 
 
4.4.1 Load Points 
 
 
Load points are defined as hot spots in the metabolic network (enzymes/metabolites) 
based on the ratio of number of k-shortest paths passing through a metabolite/enzyme 
(in/out) and number of nearest neighbour links (in/out) attached to it, compared to the 
average load value in the network.  
 
For a given metabolic network, the load l on metabolite m can be defined as (4.1) 
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where -∞ < l m (in / out) < ∞, sp! is the number of shortest paths (in/out) passing through 
a metabolite m; k is the number of nearest neighbour links (in/out) for m in the 
network; 
( )isp
!  is the total number of shortest paths and K is the sum of links in the 
metabolic network of M metabolites (where M is the number of metabolites in the 
network). Use of the logarithm makes the relevant values more distinguishable.  
 
 
The network model emphasises metabolites participating in the shortest path 
connectivity, thus minimizing the number of less important links. Since the 
connectivity is based on the metabolite structural similarity, only metabolites 
satisfying the similarity constraints are included in the pathway (for example, false 
links via ATP, ADP etc are excluded by the algorithm). A higher load value will 
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result if a greater number of shortest paths pass through a node (e.g. maximum 
number of paths) having a minimum number of nearest neighbour connectivity (e.g. 
minimum number of edges). In the bio-chemical context, load points can suggest the 
importance of an enzyme or metabolite in a given static metabolic network of various 
organisms.  
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4.4.2 Choke Points 
 
 
 
Choke points are those enzymes, which uniquely consume and/or produce a certain 
metabolite. Choke point enzymes are ranked by the load (in/out) and number of k-
shortest paths (in/out) passing through them. Since it is a reasonable assumption that 
a large number of the biochemical reactions follow the shortest path, we assume that 
the shortest path count can be a good indicator of the biochemical activity.   
 
In our graph model (Figure 41), node 6 (metabolite) and the unique edges (enzymes) 
attached to it, all represent choke points. Choke points are bio-chemically essential 
points in the network. Thus removing a single choke point enzyme (edge between 
nodes 5 & 6 or 6 & 7) from the network affects the consumption or production of the 
metabolite(s) (e.g. node 5 or 7) attached to it.  
 
Figure 41. Metabolic-centric view of a graph model. Grey colour node (6) is a choke point 
(metabolite) and thinner edges adjacent to this node (enzymes) are also choke points. This figure 
is generated by yEd (http://www.yworks.com/). 
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4.4.3 Hunting and Classification of the Potential Drug Targets 
 
In order to confer biological meaning to the graph-based approach of finding choke 
points, we proceeded in the following steps. 
 
4.4.4 Reconstruction of the Network 
 
The reconstruction of the metabolic network was done using systems biology 
knowledge like gene expression data, enzymes and metabolome data for the chosen 
pathogen (Figure 42). 
Network Reconstruction
 
Figure 42. Example of metabolic network reconstruction using systems biology knowledge i.e. 
Plasmodium falciparum. 
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4.4.5 Finding the Choke Points/Non-Choke Points Based Targets 
 
The choke points and the non-choke point enzymes and metabolites were found using 
PHT. After the calculation of the choke points and non-choke point enzymes in the 
network, they were ranked on the basis of the number of incoming shortest paths i.e as 
shown in Plasmodium falciparum  (Figure 43). 
CP Enzymes & Loads Non-CP Enzymes & Loads
Network Analysis
 
Figure 43. Finding Load and Choke points in the Pathogen and Human metabolic network. 
 
4.4.6 Classification of the Potential Drug Targets  
 
 
The potential drug targets are divided into four major classes (Figure 44). The Class 1 
contains those enzymes which are unique to the pathogen and do not share any 
homology with human genome. A homology search (Figure 45) was performed 
between the human and pathogen’s metabolic network enzymes using BLAST and 
choke points with a closest homologue with e-values < 1.0e-02 were removed. The 
Class 2 contains those enzymes, which are found in the human genome (based on the 
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enzyme nomenclature identifier) but they are not homologues to each other and these 
enzymes are non-choke point enzymes in Homo sapiens. The Class 3 enzymes are 
those enzymes that are common choke points between Homo sapiens and pathogen 
yet they are non-homologous. The Class 4 enzymes are enzymes that are choke points 
in Homo sapiens as well as the pathogen and are also homologous to each other. In 
order to corroborate the results, existing and potential drug targets from the literatures 
were also included as a control factor for our prediction. A network based 
comparative study of the choke points between pathogen and Homo sapiens was 
performed using Pathway Hunter Tool (PHT).  
Classifying the Targets
Plasmodium CP Enzymes (LP)
Human CP Enzymes (LP)
Homolog 
Enzyme
Classify
Class 1(+,-,+,-,+/-) Class 2(+,-,-,-,+/-) Class 3(+,-,-,+,+/-) Class 4(+,+,-,+/-)
Literature based
Drug targets
Pathogen Specific 
Enzymes
 
Figure 44. Potential drug targets can be divided in four major categories. Class 1 represents the 
best and Class 4 the worst. “+” implies that a particular enzyme classification criterion is true 
(read clockwise). 
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Comparative Genomics
Unique Genes
BLAST against Human Genome
Homolog Genes
 
Figure 45. Finding Homolog and Non-Homolog genes between pathogen and Human genome 
The similarity measure (refer to 2.4.7) between the two metabolites used in our 
approach is based on the similarity of their molecular structures as measured by the 
agreement of their respective 2D molecular fingerprints (Steinbeck, Han et al. 2003). 
The chosen metabolite similarity criteria (for calculating the shortest pathways) 
determine the range of network sizes and average degrees of the nodes for the various 
metabolic networks (Hattori, Okuno et al. 2003; Le, Ho et al. 2004). Thus the higher 
the global similarity (structural similarity between substrate or source and product or 
sink in a pathway over a series of intermediate metabolites) and local similarity (the 
metabolite structural similarity between a pair of consecutive metabolites) cut-off 
score (Rahman, Advani et al. 2005), the smaller is the network diameter and the 
average degree of the nodes. In the discussed example the local similarity score was 
chosen as 15% and global similarity score was chosen as 5%. 
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4.5   Results 
 
4.5.1 The Choke Point Enzyme Analysis in Corynebacterium glutamicum 
 
The choke point enzyme “1.1.1.25” in the Shikimate pathway of Corynebacterium 
glutamicum was knocked out (Figure 46). This resulted in serious repercussion in the 
growth of the bacteria in the wet lab Ξ. The “load points” also indicated this 
phenomenon as a major shift in the load graph was observed (Figure 47). 
Knock-Out
D-Erythrose
4-phosphate Phosphoenolpyruvate
7P-2-Dehydro -3-deoxy-
D-arabino -heptonate
3-Dehydroquinate
Quinate
3-Dehydroshikimate
Protocatechuate
Shikimate Chorismate
PrephenatePhenylpyruvate
Phenylalanine Tyrosine
Tryptophan
EC 1.1.1.25
 
Figure 46. The choke point enzyme 1.1.1.25 in the Shikimate pathway was reported to have high 
load value. 
                                                           
Ξ  Experiments were conducted in Prof. D. Schomburg’s laboratory of Biochemistry by his metabolome 
work group. 
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Understanding Metabolomics 
Data
1.1.1.25Mutant of C. glutamicum
A choke point enzyme
Hampers the growth
GC/MS Data
 
Figure 47. The impact of the knock-out choke point enzyme (gene) 1.1.1.25 as shown in GS/MS 
peak and the load point analysis. 
  
4.5.1.1 Load Point Analysis of Metabolic Networks between a Pathogenic and a 
Non-Pathogenic Bacterium 
 
In the pathogenic bacteria Bacillus anthracis Sterne (bat) and in non-pathogenic 
bacteria Bacillus subtilis 168 (bsu), we identified the top 10 metabolite load points 
(The top ‘10’ load points were chosen purely for convenience – both of presentation 
and of comprehensibility). The loads on the metabolites differ between the two 
bacterial networks (incoming load (Table 12) and outgoing load (Table 13)). Most of 
the metabolites in the list of top 10 load points in pathogenic bacteria Bacillus 
anthracis Sterne (bat) do not match with the load points in non-pathogenic bacteria 
Bacillus subtilis 168 (bsu).  
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Table 12. Top 10 Metabolite load points based on incoming load value in Bacillus subtilis 168 
(bsu) and Bacillus anthracis Sterne (bat). 
9
6
5
1896521594661.741.7710Oxaloacetate
78546900221.951.7311
1-(2-Carboxyphenylamino) -1' -deoxy -D-
ribulose 5' -phosphate
1736315086551.831.5913Phosphoenolpyruvate
1630614881551.771.58143-Phospho -D-glycerate
16533681111.091.79108
2-Amino -4-hydroxy -6-(erythro -1,2,3 -
trihydroxypropyl)dihydropteridine
2.11 1373710924331.78393-Phospho -D-glyceroyl phosphate
3086134146991.821.82775-Phospho -alpha -D-ribose 1 -diphosphate
34144145111.811.9186
2,5 -Diamino -6-(5'-triphosphoryl -3',4' -
trihydroxy -2'-oxopentyl) -
Not Found4345
Not 
Found
1
Not 
Found
1.96-5Cystathionine
37884613111.922.0264
2,5 -Diaminopyrimidine nucleoside 
triphosphate
41645079112.012.1143
Formamidopyrimidine nucleoside 
triphosphate
60606061112.392.2922GTP
1491212960222.62.36112-Phospho -D-glycerate
k-
Shortest
Path 
bat
k-
Shortest
Path
bsu
Links
bat
Links
bsu
Load
bat
Load
bsu
Rank
(bat)
Rank
(bsu)
Metabolites
 
 
Chapter 4                                                                                                        Load Point and Choke Point 
 
120 
 
Table 13. Top 10 Metabolite load points based on outgoing load value in Bacillus subtilis 168 
(bsu) and Bacillus anthracis Sterne (bat). 
1.828
1.847
1.856
NRNR
3427
3503
17678
NR21851NR71.638Oxaloacetate
15222551.69Phosphoenolpyruvate
2866111.5410Biotinyl -5'-AMP
2749111.514Biotin
21.944
32.132 140351099031.796
3-Phospho -D-glyceroyl 
phosphate
7745673221.77
1-(2-Carboxyphenylamino) -1' -
deoxy -D-ribulose 5' -phosphate
30473681111.71.79106
2,5 -Diamino -6-(5' -
triphosphoryl -3',4' -trihydroxy -2'-
oxopentyl) -
1655214932442.011.81853-Phospho -D-glycerate
954811233331.741.81135N6-(1,2 -Dicarboxyethyl) -AMP
34144145111.811.9194
2,5 -Diaminopyrimidine 
nucleoside triphosphate
37884613111.922.0253
Formamidopyrimidine
nucleoside triphosphate
45834725112.112.0432Acetyl adenylate
1515313028222.612.36112-Phospho -D-glycerate
k-Shortest 
Path bat
k-Shortest 
Path bsu
Links 
bat
Links 
bsu
Load 
(bat)
Load 
(bsu)
Rank 
(bat)
Rank
(bsu)
Metabolites
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4.5.1.2 Choke Point Analysis in B. anthracis - A Pathogen 
 
An analysis of the top 10 choke points ϑ in B. anthracis - a pathogen, revealed a 
number of possible drug targets against infection of B. anthracis are identified (Table 
14). 
Table 14. A comparative study of top 10 choke points in Bacillus anthracis Sterne against the 
Homo sapiens metabolic network. Top 10 Choke point enzymes in B. anthracis Sterne ranked by 
number of shortest paths. 
  
Enzyme 
Id
Enzyme Name Gene Ids
Load 
(in)
Load 
(out)
k-SP 
(in)
k-SP 
(out)
Human 
Choke 
Top Blast Hit (e-
value < 1.0e-
Top Blast Hit 
(identity)
2.4.2.7
adenine 
phosphoribosyltransferase
BAS4303 1.67 1.87 31454 31454 + 7.00E-30 42%
2.6.1.1 aspartate transaminase BAS1454 0.46 0.27 16600 16600 + 5.00E-41 30%
6.2.1.1 acetate-CoA ligase BAS2376 0.13 0.41 15831 15831 + e-109 36%
6.2.1.1 acetate-CoA ligase BAS4543 0.13 0.41 15831 15831 + e-109 40%
6.2.1.1 acetate-CoA ligase BAS4560 0.13 0.41 15831 15831 + 5.00E-89 34%
3.5.4.16 GTP cyclohydrolase I BAS1260 2.59 2.36 14341 14341 + No Homologue
No 
Homologue
3.5.4.16 GTP cyclohydrolase I BAS1421 2.59 2.36 14341 14341 + 9.00E-43 47%
4.2.1.20 tryptophan synthase BAS1161 1.67 1.26 14321 14321 - No Homologue
No 
Homologue
4.2.1.20 tryptophan synthase BAS1162 1.67 1.26 14321 14321 - No Homologue
No 
Homologue
2.7.4.6
nucleoside-diphosphate 
kinase
BAS1425 0.87 0.74 14199 14199 + 7.00E-46 57%
4.2.1.11
phosphopyruvate 
hydratase
BAS4985 1.85 2.13 13692 13692 + e-120 53%
2.4.2.18
anthranilate 
phosphoribosyltransferase
BAS1158 1.54 1.65 12622 12622 - No Homologue
No 
Homologue
2.7.4.14 cytidylate kinase BAS1407 0.82 0.92 12264 12264 + No Homologue
No 
Homologue
2.7.1.40 pyruvate kinase BAS3136 0.65 0.39 11919 11919 + 6.00E-73 42%
2.7.1.40 pyruvate kinase BAS4492 0.65 0.39 11919 11919 + e-105 44%
 
                                                           
ϑ  The top ‘10’ choke points were chosen purely for convenience – both of 
presentation and of comprehensibility 
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4.5.2 Potential Drug Targets in Plasmodium falciparum 
 
The load point and choke point strategy was implemented on the re-annotated 
metabolic network of Plasmodium falciparum, a malaria-causing agent. Most of the 
existing/potential drug targets are found by our model (Table 15). We found 31 non-
choke points based potential drug targets and 6 of the choke point enzymes targets 
were found in only one of the malaria life cycle stages. We propose new 29 choke 
point based anti-malarial potential drug targets. Three proven drugs- fosmidomycin 
(acting on EC 1.1.1.267), Trimethoprim/ Proguanil/ Pyrimethamine (inhibiting EC 
1.5.1.3) and Sulfadiazine/Sulfametopyrazine/ Sulfisoxazole/ Sulfoxone (inhibiting EC 
2.5.1.15) are successfully identified by our model. Hence this result, which was used 
as a control, further highlights the usefulness of our modelℑ. 
 
Table 15. Drug Targets in Plasmodium falciparum, and its relevance to our prediction model. 
Prediction Status
Dapsone , sulfone /sulfonamide --
+ All, -
Sporozoite
2.5.1.15
fosmidomycin--
Virtual and 3 
stages
1.1.1.267
Atovaquone+++ All1.10.2.2
Dapsone--
+ All,  -
Sporozoite
2.7.6.3
Halofantrine / QuinineNANANA1.14.13.67
Halofantrine
+-Non-CP3.6.3.14
DapsoneNANAVirtual4.1.2.25
DapsoneNANANA1.14.13.80
Sulfadiazine/ Sulfametopyrazine / 
Sulfisoxazole / Sulfoxone
++Non-CP1.3.3.1
Trimethoprim / Proguanil / 
Pyrimethamine
+-
Merozoite , 
Sporozoite
2.1.1.45
Trimethoprim / Proguanil / 
Pyrimethamine
+++ All, - Ring 1.5.1.3
Drugs/InhibitorsHomologyCP H. sapiensCP P.falTargets
Non-Choke Points
Non-Choke Points
 
                                                           
ℑ  For details please refer the CUBIC project thesis (report) of T. Biru (2005-2006) and J. Padiadpu 
(2004-2005). 
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4.5.3 Potential Drug Targets in Mycobacterium tuberculosis 
 
The proven potential drug targets, which exist against the tuberculosis producing 
pathogen Mycobacterium tuberculosis, was analysed by our model (Table 16). The 
results conjure similar prediction rates as observed in the case of the malaria parasite 
Plasmodium falciparum. The non-pathway based drug targets were not picked up by 
our method as this model is exclusively designed for predicting targets in metabolic 
networks (Table 17). 
Table 16. Classification of the drug targets in Mycobacterium tuberculosis 
+
III
III
III
II
I
I
I
Class
thiolactomycinMT2306fab2.3.1.41
pyrazinamideMT0486cmaA12.1.1.79
Drug/InhibitorGene IDGenesEnzyme
kanamycinMT0275aac2.3.1. -
isoniazidMT1959katG1.11.1.6
PASMT2834thyA2.1.1.45
Clavulanic acidMT2128bla3.5.2.6
cycloserineMT3059ddlA6.3.2.4
Isoniazid , ethoniamide , triclosanMT1531inhA1.3.1.9
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Table 17. Classification of the drug targets in Mycobacterium tuberculosis 
No path 
No path 
No path
No path
+
+
+
Class Drug / InhibitorGene IDGenesEnzyme
StreptomycinMT0720rpsLnone
AmikacinMT0720rpsLnone
CapreomycinMT0680rplJnone
oxfloxacinMT0006gyrA5.99.1.3
RifapenteneMT0696rpoC2.7.7.6
RifabutinMT0695rpoB2.7.7.6
RifampicinMT0695rpoB2.7.7.6
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5 Discussion 
 
Metabolic network analysis will play a major role in “Systems Biology” in the future. 
Molecular networks represent the backbone of molecular activity within the cell. 
Recent studies have taken a comparative approach toward interpreting these networks, 
contrasting networks of different species and molecular types, and under varying 
conditions. 
 
5.1 Network Analysis 
 
The shortest path between metabolites can be calculated by various methods 
(analytical assumption or biochemical knowledge). We proposed a novel method, 
which uses biochemical information to calculate the shortest path in the metabolic 
network. In order to achieve such a meticulous approach we have mapped each 
substrate in the bio-chemical reaction to its corresponding product (refer to section 
2.1.5 and 2.1.6). For the calculation of the shortest paths the two biochemical criteria 
“local” and “global” structural similarity were used, where “local similarity” is 
defined as the similarity between two intermediate molecules and “global similarity” 
is defined as the amount of conserved structure (refer to section 2.5.2) found between 
the source metabolite and the destination metabolites after a series of reaction steps 
(refer to section 2.4.7). These two criteria helped us to achieve bio-chemically valid 
shortest path (refer to section 2.5.2 and 2.5.3) in the metabolic network without 
making any analytical presumptions (elimination of the frequently occurring 
metabolites in the network). 
 
The atomic mapping algorithm developed by us handles the biochemical mapping in 
the network, while dynamically finding the paths. Since we use binary fingerprints-a 
heuristic method (refer to section 2.4.4.1) to find biochemical similarity, we might get 
some false positive mapping in the network. Though it keeps track of the structural 
changes molecular fingerprint is not a very sensitive measure. In future it will be a 
useful to change fingerprints with actual atom counts (of the metabolites) for keeping 
track of the conserved /matched chemical moieties in the pathway (refer to the MCS 
method on 2.4.5). Another potential drawback of this method is given by the fact that 
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not all metabolites in the metabolite databases have structures (e.g. macromolecules 
like proteins or nucleic acids, or generic molecules like “an alcohol”), as a result of 
which, the user may miss some connectivity due to lack of structural information.  
 
The shortest path between source and destination metabolite is the minimum number 
of reaction steps between them. We consider the metabolic pathway in our system to 
be a directed graph, and all the edges (reactions) share the same cost (here 1). Hence 
this does not lead us to NP-complete problem as one can calculate the k-shortest path 
between two metabolites using BFS (Breadth First Search) algorithm. The 
biochemical knowledge about the chemical similarity (refer to section 2.4.2, 2.4.5 and 
2.4.6) has been used to satisfy the constraints (similarity) with BFS algorithm in order 
to calculate k-shortest paths between two metabolites (source and destination). This 
means that the runtime of the tool depends on the metabolites and reactions present in 
an organism. We are able to generate all possible k-shortest paths between two 
metabolites under given criteria of global and local similarity.  
 
In order to cross-check this result it is possible to switch off the “Atom Mapper” 
(Local similarity) and “Atom Tracer” (Global Similarity) options thereby performing 
the search on the ligand-number-based mapping obtained from the KEGG reaction 
database. On the other hand the power and biochemical relevance of having local 
similarity and global similarity is very high. In the future we plan to provide non-
standard structural information for these metabolites in order to allow the inclusion of 
such reactions.  
 
The impact of local similarity is more than global similarity while path finding (refer 
to 2.5.3.1). This may be because the number of connectivities in the network is 
directly proportional to the local similarity score. The strength of using shortest path 
with biochemical knowledge is very well cited in this example (refer to section 2.5.1, 
2.5.2). The shortest path between pyruvate and L-lysine resulted in 11 steps in KEGG 
pathway map whereas by using chemical knowledge we found a shorter path of length 
7 (refer to 2.5.3). Thus such missing links can be explored with this algorithm which 
can be very helpful while interpreting –omics data set. 
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A comparative study of the network of E.coli was performed (refer to 2.5.4). A subset 
of shortest path (between beta-d-glucose and pyruvate) was found to be similar at the 
biochemical level. When the metabolic network of C. glutamicum was compared with 
E.coli (refer to section 2.5.4.2 and 2.5.4.1) it was evident that they differ both in terms 
of connectivity and shortest path. It is clear that at the biochemical level the top 10 
hubs (in both the organism) based on shortest path may be a better criterion to 
understand the network rather than just connectivity. On the other hand one can also 
observe that highly connected metabolites do not occur as top scores in shortest path 
hubs. While performing the shortest path analysis (distribution of shortest paths refers 
to section 2.5.4.3) it was also evident that E.coli has a greater number of alternate 
pathsΨ although both the genomes have approximately similar average path length. 
This further highlights the strength of our algorithm that by using chemical 
information for calculating pathways, we can achieve biochemical meaningful results. 
 
Thus we are able to calculate a valid shortest path in network. Using Pathway Hunter 
Tool (PHT) we are able to perform comparative studies between the genomes i.e. 
hubs, alternate path, paths under constraints (via not via metabolites etc).  
 
 
 
 
 
 
 
 
                                                           
Ψ This might also be because of the fact that E.coli has been a model organism since long, hence we 
have better understanding of the genome. 
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5.2 Pathway Alignment 
 
With the stock pile of already sequenced genomes ever increasing, computational 
reconstruction of metabolic pathways becomes a crucial step for metabolic pathway 
analysis (Sharan and Ideker 2006). We present a novel method to perform metabolic 
pathway alignment from the reconstructed metabolic networks of various genomes. 
Our method highlights both conserved as well as diverged parts in the metabolic 
networks of various genomes. This study further can be used to bring out the alternate 
path, iso-enzymes and evolutionary relationship that may give us a better 
understanding of the genomes. The enzyme-percentage matrix (refer section 3.4.6 ) 
and enzyme-enzyme matrix can not only provide information about the enzyme 
preference in the genomes but it can also help us to annotate organisms based on 
evidence of molecular interactions. 
  
The new tool provides flexibility to the user both at the level of selection of genomes 
based on the existing phylogenetic profile and pathway alignment based on the chosen 
source (substrate) and destination (product) metabolite. The user can also build 
reference matrices from the chosen genomes (network topology) and set the 
abstraction level of the graph based on the molecular similarity (local and global 
similarity) as implemented in PHT. Certain enzymes can be skipped while aligning 
the pathway by the option “not via enzymes” or “not via metabolites” thereby giving 
the user complete control over the pathway elucidation.  
 
Any pathway alignment without gap (insertion/deletion) may sound very stringent, 
especially since almost all the annotated metabolic pathways have gaps. To overcome 
this bottleneck in the pathway alignment we provide the user with a gap insertion 
option thus giving the user a new insight into the pathways. Further evidences about 
the existence of the suggested enzymes (insertions/gaps) can be obtained by looking 
into different annotation database. The “gap filling” or “hole filling” idea in the 
metabolic alignment may take more computation time but it yields high dividends for 
the users (refer section 3.4.10 and section 3.5.6). 
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From the perspective of the algorithm, pathway alignment is an NP-complete problem 
as finding all the possible paths (of various lengths) in the network is not possible 
(refer section 3.4.11). Hence we allow a maximum of five gaps in the network as it 
affects the run time due to increase in the search space. We intend to include an 
automated annotation module for the suggested insertions (enzymes) while 
performing the pathway alignment. We expect our tool to be of use in different 
applications and of value to a wide range of users including pharmacologists, 
metabolic engineers and in genome annotation. 
 
In the results section a comparative study between two bacilli strains (pathogenic and 
non pathogenic) were performed. They exhibited similar network topology except that 
they had alternate paths of different lengths (refer to section 3.5.3). Thus we need a 
method to amplify these changes/variations in the genomes.  
 
Hence we performed a pathway alignment between four pathogens and a non- 
pathogenic bacterium (refer to section 3.5.4). The results were promising as one could 
expect preferences of various enzymes/metabolites in these genomes. The pathogenic 
strains Escherichia coli O157:H7 and Pseudomonas aeruginosa have a shorter 
shortest path between them, while Mycobacterium tuberculosis CDC1551, Bacillus 
anthracis Sterne, and a non-pathogenic bacteria Bacilus subtilis have a longer shortest 
path for the same conversion (refer to section 3.5.4, 3.5.4.1). The enzymes preferences 
between them also vary (refer to section 3.5.4.2). The pathogenic strain of Bacillus 
anthracis at step 5 does not use enzyme EC 3.6.1.1., while the non-pathogenic strain 
Bacilus subtilis uses this enzyme. The colour codes further highlight that this enzyme 
is only used by 30% to 40 % of bacteria (although this knowledge is limited to the 
present data). The bar charts above the header further highlight the enzyme 
preferences at certain steps of conversion between these genomes. Thus the global 
information about enzyme usage in bacteria and local information about enzyme 
preference at various steps of conversion is very well captured by this representation.  
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Further investigation of the metabolite connectivity in the metabolic-centric view of 
the alignment makes clear that certain metabolites are conserved and some of them 
vary (refer to 3.4.9). Invariably, it is the side metabolites (or non-connecting) that vary 
in the pathway rather than the connecting metabolites. The impact of such variation 
will change the Gibbs energy profile of the pathway and its dynamics. Thus the Gibbs 
energy perspective gives us an idea of the thermodynamic feasibility of the reactions.  
 
Since the present network suffers with gaps, pathway alignment that allows filling of 
these gaps is very beneficial. One such example is demonstrated in the section 3.4.10. 
The pathway alignment between E.coli and H.pylori was performed with one gap. We 
were successfully able to predict a potential missing enzyme in this pathway (refer 
section 3.5.6). It was evident from the alignment that if we insert an enzyme EC 
2.7.1.40 then we will be able to complete the path. Since this enzyme is used by 80% 
of the genome, it was highly probable that this was a good hit. On the other hand the 
Gibbs energy profile was also favourable, as the connecting metabolites do not 
change. Another extension can be the search for the homologous gene in H.pylori, 
which may code for this enzyme.  
 
Thus we define a novel method examining metabolic capabilities of various genomes 
in the light of systems biology to bring out topological complexity and the crosstalk 
between the connectivity (Rahman, Jonnalagadda et al. 2005). Along with 
highlighting the conserved/diverged enzymes in the pathways, our study also provides 
a local and global outlook to metabolic pathway alignment. We are able to predict 
potentially missing enzymes in the pathway. The metabolic pathway flexibility and 
their cross-talk will highlight the adaptation potential in the genomes and allow us to 
tap organism-specific enzymes for potential drug targeting (especially in drug-
resistant strains of parasites).  
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5.3 Potential Drug Targeting using Load Point and Choke Point 
 
In certain common diseases, e.g., diabetes and obesity, metabolic dysfunction is a core 
aspect of the patho-physiology. In others, such as cancer, it is secondary, but 
nevertheless required for disease progression, with, for example, malignant cells 
requiring increased glycolytic metabolism and nucleic acid synthesis to be able to 
divide rapidly in an oxygen-deficient tumor environment. Notably, many important 
drugs (e.g., certain antibiotic and anticancer agents and the leading cholesterol 
lowering agents) target specific metabolic reactions. Hence, an improved 
understanding of metabolism is likely to have great value in developing better drugs 
and disease treatments.  
 
Drug target identification based on “omics” networks (Giaever, Flaherty et al. 2004; 
Holzhutter and Holzhutter 2004; Yeh, Hanekamp et al. 2004; di Bernardo, Thompson 
et al. 2005) is a very promising approach that has only recently become possible. The 
concept of choke points (Dawson and Elliott 1980) in a given network contributes 
effectively in the identification of the lethality/bottleneck (here potential drug targets) 
in a network. Since a high load on a certain enzyme means that a large number of 
shortest paths go through it, therefore indicating a position in the central metabolism, 
we assume that ranking choke points on the basis of load will move enzymes with a 
higher probability of biochemical lethality to the top of the candidate list. A 
comparative study of choke points with the human metabolic network is essential to 
identify possible interference of the drugs with the human metabolism which might 
lead to side effects. It has to be kept in mind though, that presently a large number of 
genes have unidentified functions which could lead to erroneous prediction of choke 
points. For example, often drug targets are identified by a unique pathogen-specific 
metabolic activity, as in the case of reverse transcriptase in the case of HIV (Imamichi 
2004). However, the screening of the entire metabolic network of the pathogen to find 
choke point-based potential drug candidates followed by a comparative study with 
human metabolic network provides additional targets. Examples are the anti-malarial 
drugs (Sixsmith, Watkins et al. 1984) pyrimethamine and cycloguanil, targeting a 
choke point enzyme dihydrofolate reductase (1.5.1.3) (also a human homologue) in 
Plasmodium falciparum with some side effects on humans but lethal to the parasite.   
 132 
 
Using better pathogen genome annotation (refer to section 4.4.4) and the 
robust algorithm in the Pathway Hunter Tool (Rahman and Schomburg 2006), we 
provide a strong foundation for the identification of Choke Point enzymes by 
metabolic network analysis (refer to section 4.4.6). This has resulted in the prediction 
and classification of potential drug targets in few of the most lethal disease-causing 
organisms. As already proved by previous studies, identifying Choke Point enzymes 
is one of the systematic methods of identifying potential metabolic drug targets (Yeh, 
Hanekamp et al. 2004) (Rahman and Schomburg 2006). This robust method enables 
the prediction of potential targets in metabolic pathways of a pathogenic organism 
(refer to section 4.5.3 and 4.5.2). The lack in functional annotations poses the major 
drawback in any analysis of a metabolic network due to the lack of connecting 
enzymes in the pathways. For example, in M. tuberculosis we have many hypothetical 
proteins belonging to the unique PE (Pro-Glu) and PPE (Pro-Pro-Glu) protein 
families. We may have additional Choke Points due to this lack of connectivity (holes 
in the network), making it a unique enzyme in the pathway. We may also lack few 
critical enzymes due to gaps in the functional annotations. An important and better 
annotation of the pathogen genome would greatly reduce the false Choke Point 
enzymes in the metabolic network. 
 
  There are few gaps in the pathways for which no enzyme(s) has been detected 
in the genome. This implies that either, a) there are enzymes in the genome that have 
not been identified, or b) enzymatic functions have not been assigned to the identified 
proteins, or c) an alternate pathway in the organism exists that does not involve the 
reaction, or d) there is parasite importation of the enzymatic activity from the host. If 
the organism produces these missing enzymes, they must reside in the un-annotated 
(functional) regions of the genome. If the organism does not produce them, they or 
their products may be imported from the host, a variant pathway that does not use the 
reaction may exist (refer to 3.4.10 for hole filling), or the pathway may not exist at all. 
Such discoveries are very important in drug discovery (Morett, Korbel et al. 2003). 
This further fortifies our study and makes it valuable to the immunological and 
molecular research community as alternate paths are promising targets of drug 
discovery. 
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In addition, we found that lack of sequence similarity has a predictive value 
for considering a choke point enzyme as a biologically validated drug target in 
pathogens. Although we have more than hundred choke point enzymes in each studied 
pathogens, the classification based on the relevance with the human pathway 
narrowed down the counts to only few critical enzymes with very few exceptions. 
Enzymes with no significant sequence similarity to any known human enzyme or 
protein make these predicted choke point enzymes very important as targets for drug 
designers (refer to section 4.4.5, 4.4.6, and 4.4.3). Even enzymes with some sequence 
similarity (low e-value) can be considered as drug targets; given the fact that many 
such enzymes are already targets for currently used drugs (Rahman 2006) (Table 15), 
(Table 16) and (Table 17). 
 
We were successful in finding new potential drug targets in pathogen M.tb and 
malarial parasite (P.fal). Apart from this we also found few choke point drug targets, 
which already exist as successful drugs thus complimenting our method ℵ. Most of the 
proposed choke points found support in the existing literature. This fortifies our 
concept and brings out the effectiveness and robustness of our prediction method. The 
results obtained from our in silico method illustrate that many proposed drug targets 
in the literature are predicted Choke Point enzymes (Table 15). The effectiveness of 
our Choke Point analysis for target prediction can be improved with refinement of the 
underlying metabolic network. The structure of the metabolic network will improve 
with further annotation of the metabolic functions in the organism, as well as the 
incorporation of additional types of information, expression at different cellular 
growth phases and cellular localization of specific enzymes (refer to section 4.4.4). 
 
                                                           
ℵ  For Further details please refer CUBIC project report of  T. Biru (2005-2006) and J. Padiadpu (2005-
2006). 
 134 
 An analysis of the top 10 choke points (The top ‘10’ choke points were 
chosen purely for convenience – both of presentation and of comprehensibility) in B. 
anthracis - a pathogen, is presented (Table 14). In (Table 14), a number of possible 
drug targets against infection of B. anthracis are identified. We found that the 
enzymes tryptophan synthase (EC: 4.2.1.20) and anthranilate 
phosphoribosyltransferase (EC: 2.4.2.18) could be effective potential drug targets 
(refer to section 4.5.1.2). Neither of these enzymes are chokepoints in the human 
metabolic network nor do they share a significant homology with the human genome 
(Table 14). This means that blocking these enzymes might affect the pathogen but not 
the human as there exists an alternate pathway.  
 
This approach may contribute to the first identification of potential target 
enzymes for rational drug design. However, it must be noted that the absence of 
complete pathway information may lead to false identification of choke points. 
Additional computational, biological and/or experimental methods or data will further 
narrow down the list of potential drug targets.  
 
To summarize, our analysis is based on the, a) sound biochemical significance 
obtained from experimental facts as stated in the literature, b) a comparative study of 
human and pathogen metabolic network and c) sequence similarity (homologue) 
search of functional assignment.  
 
Although we have developed a robust method to predict the potential targets in 
metabolic pathways of organisms in general, there is always room for further 
improvement. Providing a complete and better annotation in vivo (thereby reducing 
the identification of false Choke Point enzymes and providing previously unreported 
Choke Point enzymes in the metabolic network) is one of the first steps in this 
direction. The current analysis includes only the completely annotated enzymes in 
each organism. Including all the available enzymes for the organisms, such as putative 
enzymes, may complete the analysis of the metabolic network. The enzymes obtained 
as Choke Point enzymes in the analysis can be considered as potential drug targets 
although many other issues need to be taken into consideration (e.g. Non-Choke Point 
enzymes and their impact). Another approach could be combining Choke Point 
analysis with chemo-genomic profiling (micro-array data) (di Bernardo, Thompson et 
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al. 2005) to observe functional responses on the targets. Our provisional targets need 
to be examined further, both computationally and experimentally for these additional 
features.  The rapid emergence of multi-drug resistant strains of these potentially 
lethal pathogens calls for the identification of new targets. The discovery of new 
targets may lead to a drug formulation that would be able to counteract the resurgence 
of these diseases.  
 
Our results highlight the local and global properties of complex biological metabolic 
networks. Thus the load (in/out) of metabolites is a more global indicator of their 
importance, as compared to mere connectivity information. The network model and 
algorithm presented can process the information contained in the topology of the 
metabolic network and extract knowledge about the function, role and importance of 
the metabolites in a network. The extended graph-based choke point concept can 
facilitate drug discovery and ranking choke points based on their load values may be a 
likely pointer to the lethality level of such potential drug targets in the network. 
Further study and comparative analysis of various metabolic networks based on our 
network model can be beneficial for in vivo and in vitro studies (refer to section 
4.5.1). As a note of caution we would like to add that presently such an analysis is 
limited by the limited accuracy and completeness of pathway annotations and by the 
lack of knowledge of the proteins actually present in a certain state of the cell.  
 
The algorithm described has been implemented in the Pathway Hunter Tool (PHT) 
with the aim of identifying enzymes for potential drug targets and designing synthetic 
networks with highly specialised metabolic functions.  
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6 Outlook 
 
Metabolic network analysis will play a major role in “Systems Biology” in the future. 
Molecular networks represent the backbone of molecular activity within the cell. 
Recent studies have taken a comparative approach toward interpreting these networks, 
contrasting networks of different species and molecular types, and under varying 
conditions. The knowledge about metabolites involved in the cellular process will 
improve the connectivity information. We need to substitute the molecular fingerprint 
score while tracking the changes in the metabolite structure by the actual count of the 
atoms. Apart from finding shortest path, a robust algorithm is needed to find all the 
paths (path of variable lengths between fixed source and destination) and their impact 
on the Gibbs energy profile. This will also improve pathway alignment profiles. We 
can further investigate the role of small molecules and their impact on the enzymatic 
activity by understanding the reaction mechanism and evolutionary stature of the 
enzymes. Finding choke point(s), which is lethal to multiple organisms, will be very 
helpful. We can automate the drug identification process by integrating text mining, 
micro-array, and proteome and metabolome data for network analysis.  
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